Skip to main content
. 2022 Jul 1;26(7):567–576. doi: 10.5152/AnatolJCardiol.2022.1597

Table 1.

Demographic Characteristics and Echocardiographic Results

CHA2DS2-VASc Score Risk Classification Low-Medium Risk (n = 349) High Risk (n = 2243) P Total (n = 2592)
Gender (female), n (%) 105 (30.1) 1333 (59.4) <.001 1438 (55.5)
Age (years) 56.2 ± 11.6 70.5 ± 9.4 <.001 68.7 ± 11.1
Body mass index (kg/m2) 27.9 ± 3.6 28.2 ± 4.0 .135 28.2 ± 3.9
Heart rate (minute) 85.7 ± 17.7 87.9 ± 18.2 .035 87.6 ± 18.2
Systolic blood pressure (mm Hg) 124.5 ± 15.2 128.5 ± 17.6 <.001 128 ± 17.4
Diastolic blood pressure 76.3 ± 10.0 77.9 ± 11.6 .014 77.7 ± 11.4
Ischemic CMP, n (%) 29 (8.3) 644 (28.7) <.001 673 (26)
Dilated CMP, n (%) 11 (3.2) 123 (5.5) .067 134 (5.2)
Hypertrophic CMP, n (%) 2 (0.6) 18 (0.8) .649 20 (0.8)
COPD, n (%) 35 (10) 417 (18.6) <.001 452 (17.4)
DVT, n (%) 0 6 (0.3) .420 6 (0.2)
PE, n (%) 1 (0.3) 13 (0.6) .419 14 (0.5)
Thyroid dysfunction, n (%) 13 (3.7) 77 (3.4) .782 90 (3.5)
GFR (mL/min) 58.4 (42.8-94) 41.0 (28.5-64.8) <.001 43.8 (29.9-68)
CRF, n (%) 180 (51.6) 1609 (71.7) <.001 1789 (69)
Smoker, n (%) 37 (10.6) 114 (5.1) <.001 151 (5.8)
HT, n (%) 79 (22.6) 1620 (72.2) <.001 1699 (65.5)
DM, n (%) 16 (4.6) 560 (25) <.001 576 (22.2)
Ischemic CVD/TIA, n (%) 4 (1.1) 204 (9.1) <.001 208 (8)
Hemorrhagic CVD, n (%) 3 (0.9) 19 (0.8) .585 22 (0.8)
EF (%) 55.5 ± 7.8 49.8 ± 10.9 <.001 50.5 ± 10.7
LA diameter 41.8 ± 6.6 45.4 ± 6.8 <.001 44.9 ± 6.9
LA volume 62.9 ± 33.9 71.6 ± 31.3 <.001 70.5 ± 31.8
LA thrombus, n (%) 8 (2.3) 16 (0.7) .004 24 (0.9)

P value of <.05 shows statistical significance.

CMP, cardiomyopathy; COPD, chronic obstructive pulmonary disease; DVT, deep venous thrombus; PE, pulmonary embolism; GFR, glomerular filtration rate; CRF, chronic renal failure; HT, hypertension; DM, diabetes mellitus; CVD, cerebrovascular disease; TIA, transient ischemic attack; EF, ejection fraction; LA, left atrium.